Page 147 - Small Animal Internal Medicine, 6th Edition
P. 147

CHAPTER                                    6
  VetBooks.ir

                     Acquired Valvular and


                          Endocardial Disease













            DEGENERATIVE ATRIOVENTRICULAR                        downregulated genes relate to formation of force-resistant
            VALVE DISEASE                                        collagen bundles, basement membrane structure, matrix
                                                                 metalloproteinases involved in collagen maturation and
            Chronic degenerative atrioventricular (AV) valve disease is   elastic fiber formation, and sarcoplasmic reticular calcium
            the most common cause of heart failure in the dog; it is   reuptake.
            estimated to cause more than 70% of the cardiovascular   Chronic  mechanical  stress  on  valve  leaflet  edges  from
            disease recognized in this species. Almost all small-breed   repeated impact is thought to play a role in initiating the
            dogs develop some degree of valve degeneration as they age;   myxomatous degeneration process. Subsequent alterations
            many dogs of larger breeds do as well. Degenerative valve   in valve interstitial and endothelial cell phenotype and func-
            disease also has been called endocardiosis, mucoid or myxo-  tion are important to this process. These changes cause
            matous valvular degeneration, chronic valvular fibrosis, and   disruptions in normal extracellular matrix homeostatic
            other names. Because clinically relevant degenerative valve   mechanisms, leading to characteristic changes in the organi-
            disease is rare in cats, this chapter focuses on canine chronic   zation, quantity, and distribution of extracellular matrix
            valvular disease. The mitral valve is affected most often and   components. The major mediator of myxomatous degenera-
            to a greater degree, therefore degenerative valve disease   tion appears to be activated valve interstitial cells, which
            usually is referred to as chronic (or degenerative or myxo-  become transformed from their normal fibroblastic pheno-
            matous) mitral valve disease (CMVD). Degenerative lesions   type into a myofibroblastic, α-smooth muscle actin-positive
            also affect the tricuspid valve in many dogs; however, iso-  staining form (αSMA). The increase in these transformed
            lated tricuspid involvement is uncommon. Thickening of the   cells promotes valve matrix remodelling. Altered activity of
            aortic and pulmonic valves sometimes is observed in older   the various catabolic extracellular matrix enzymes (such as
            animals but rarely causes more than mild insufficiency.  matrix  metalloproteinases, collagenases, and elastases)
              The preclinical phase of CMVD is prolonged. Early valve   occurs during the process of valve degeneration, which leads
            lesions  are  evident  only  on post-mortem  exam.  As  the   to increased collagen, decreased elastin, and increasing valve
            degenerative process continues, valve insufficiency (regurgi-  stiffness. Transforming growth factor-β (TGF-β) and sero-
            tation) with progressively worsening mitral regurgitation   tonin (5-HT) signaling also appear to be involved in CMVD
            (MR) and volume overloading of the adjacent atrium and   pathogenesis. Localized production of TGF-β occurs in
            ventricle eventually develop over a period of years. Although   affected valves, and expression of TGF-β subtypes and their
            many affected dogs do develop congestive heart failure   receptors is  increased.  Through  a mechanism involving
            (CHF) and other complications, many others do not.   TGF-β, 5-HT induces the transformation of valve interstitial
                                                                 cells into their activated form. Valve endothelial cell signal-
            ETIOLOGY AND PATHOPHYSIOLOGY                         ing, basement membrane damage, phenotypic changes in
            Multiple factors are involved in the development of CMVD.   valve endothelial cells, and increased release of vasoactive
            Although the structural and cellular changes have been fairly   substances are involved in the pathogenesis of CMVD.
            well delineated, the molecular mechanisms and biochemical   Several mediators are known to increase activity of matrix
            changes involved are less clear. Studies have shown differen-  metalloproteinases, including angiotensin II, endothelin,
            tial expression of multiple genes, with some being upregu-  norepinephrine and other catecholamines, tumor necrosis
            lated and others downregulated. Affected genes appear   factor (TNF)α, interleukin-1β, and possibly oxidative and
            related to cell signaling, metabolism, extracellular matrix,   mechanical stresses.
            inflammation, cardiovascular development, basement mem-  Progressive thickening of the valve spongiosa layer occurs
            brane structure, and other functions. Some functions of   as deposition of glycosaminoglycans (GAGs), proteoglycans,

                                                                                                             119
   142   143   144   145   146   147   148   149   150   151   152